Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02052557 · ClinicalTrials.gov registry record · Phase 4
The Effect of Exparel on Post Operative Pain and Narcotic Use After Colon Surgery
A Phase 4 study, sponsored by Des Moines University.
- Completed
- Registry status
- Phase 4
- Development phase
- 51
- Enrollment target
NCT02052557 is a Phase 4 study that has completed, run by Des Moines University. The registered enrollment target is 51 participants.
The verdict
NCT02052557, a Phase 4 study, has completed, sponsored by Des Moines University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 51 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the effect of Exparel on pain control and patient outcome after colon resection. The investigators will evaluate the clinical course of the patients who receive exparel as compared to the patients who do not receive exparel. Exparel is a 72 hour bupivacaine which is slowly released from lysosomes over the course of three days. A long acting local anesthetic should provide better pain control than conventional bupivacaine which has a 3.5 hour half-life.
Interventions
- DRUG Bupivacaine
- DRUG Bupivacaine liposome suspension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2013-02 |
| Est. Completion | 2013-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02052557
The ClinicalTrials.gov registry entry for NCT02052557 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Des Moines University, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT02052557 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02052557 about?
NCT02052557 is a clinical study titled "The Effect of Exparel on Post Operative Pain and Narcotic Use After Colon Surgery". The purpose of the study is to evaluate the effect of Exparel on pain control and patient outcome after colon resection. The investigators will evaluate the clinical course of the patients who receive exparel as compared to the patients who do not receive exparel. Exparel is a 72 hour bupivacaine wh...
What is the current status of trial NCT02052557?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 51 participants. The study started on 2013-02. Estimated completion is 2013-12.
What interventions are being tested in trial NCT02052557?
The interventions under investigation include: Bupivacaine (DRUG), Bupivacaine liposome suspension (DRUG).
Who is sponsoring clinical trial NCT02052557?
This trial is sponsored by Des Moines University, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.